Seeger Weiss Partner Shauna Itri Writes on COVID-19 Whistleblower Cases in Reuters

Seeger Weiss partner Shauna Itri was featured in Reuters, authoring a piece on how whistleblower claims can stop COVID-19 fraud. In the piece, “Using the False Claims Act to Combat COVID-19 Fraud,” Itri wrote: “Even though the pandemic began more than two years ago, it is likely that the widely predicted increase in qui tam-related […]

April 6, 2022

Seeger Weiss partner Shauna Itri was featured in Reuters, authoring a piece on how whistleblower claims can stop COVID-19 fraud. In the piece, “Using the False Claims Act to Combat COVID-19 Fraud,” Itri wrote:

“Even though the pandemic began more than two years ago, it is likely that the widely predicted increase in qui tam-related recoveries stemming from COVID-19 fraud will only begin to be seen this year. Fraudulent schemes take time to develop, be uncovered, and investigated either by the government or private counsel retained by the relator. Moreover, qui tam actions are filed in camera and under seal for 60 days, and the government may further request that a court extend the seal during any investigation into the matter. Nonetheless, we can look to existing enforcement actions to see what types of COVID-19 fraud whistleblowers will likely uncover.”

Shauna Itri has extensive experience representing relators in False Claims Act lawsuits as well as tax and securities whistleblowers with claims under the IRS and SEC whistleblower programs.

The full article can be found here.

Related News

September 9, 2024
Seven Seeger Weiss Partners Named to 2025 Lawdragon 500 Leading Litigators in America List

Seeger Weiss is proud to announce that seven partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, Matt Pawa, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators […]

Read More
September 6, 2024
Seeger Weiss Partner Parvin Aminolroaya Featured on CBS News Discussing Ozempic Litigation

Seeger Weiss partner Parvin Aminolroaya recently appeared on CBS News to discuss ongoing litigation against pharmaceutical companies Novo Nordisk and Eli Lilly over their popular GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. Our firm represents patients across the country who allege they suffered serious medical complications while taking these drugs and […]

Read More
August 20, 2024
Seeger Weiss Partner Shauna Itri Appointed to Plaintiff’s Executive Committee in AT&T Data Breach Multidistrict Litigation

PHILADELPHIA, PA – Seeger Weiss partner Shauna Itri has been appointed to the Plaintiff’s Executive Committee in the AT&T Inc Customer Data Security Breach Litigation by the Honorable Judge Ada Brown of the Northern District of Texas, Dallas Division. This litigation consolidates dozens of class action lawsuits stemming from a data breach earlier this year, […]

Read More